ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2388 • 2015 ACR/ARHP Annual Meeting

    Variations in Hip Morphology Are Associated with Hip Symptoms: Preliminary Results from a Large Community-Based Cohort

    Amanda E. Nelson1, Jamie L. Stiller1, Xiaoyan A. Shi1,2, Jordan B. Renner3, Todd A. Schwartz4, Nigel K Arden5 and Joanne M. Jordan1, 1Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 2SAS Institute, Inc, Cary, NC, 3Radiology, University of North Carolina, Chapel Hill, NC, 4School of Nursing, University of North Carolina, Chapel Hill, NC, 5Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Alterations in hip morphology, such as femoroacetabular impingement, have been associated with incident hip OA and total hip replacement (THR), but associations of these…
  • Abstract Number: 452 • 2015 ACR/ARHP Annual Meeting

    Associations Between Arthritis Patient, Disease-Specific and Provider Characteristics and Medication Information Source Use

    Lorie Geryk1, Susan J. Blalock2, Robert DeVellis3, Joanne M. Jordan3 and Delesha Carpenter4, 1Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, 2Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, 4Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Asheville, NC

    Background/Purpose: Few studies have described how patient, disease-specific, and provider factors are associated with medication information source use among arthritis patients. We address this research…
  • Abstract Number: 2394 • 2015 ACR/ARHP Annual Meeting

    B-Flow Imaging of Synovial Tissue in Osteoarthritis

    Ralf G. Thiele1, Allen P. Anandarajah2 and Christopher T. Ritchlin3, 1University of Rochester Medical Center, Rochester, NY, 2Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, 3Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Development of disease modifying medication for osteoarthritis (OA) is desirable, but the target tissue of such treatment remains unclear. We have previously shown that…
  • Abstract Number: 534 • 2015 ACR/ARHP Annual Meeting

    Antibodies to Malondialdehyde-Acetaldehyde Adducts Are Highly Expressed in Rheumatoid Arthritis Synovial Fluid 

    Rafid Rahman1, Geoffrey M. Thiele2, Andy Hollins3, Michael J. Duryee1, Daniel Anderson3, Bartlett Hamilton4, Kaleb Michaud5, Lynell W. Klassen6 and Ted R. Mikuls3, 1Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Omaha, NE, 4University of Nebraska Medical Center and Omaha VA Medical Center, Omaha, NE, 5Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE, 6Dept of Internal Medicine, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose:   Malondialdehyde-acetaldehyde (MAA) adducts are expressed in synovial tissues in rheumatoid arthritis (RA). Post-translational MAA modifications are pro-inflammatory, promoting robust anti-MAA antibody responses that…
  • Abstract Number: 2407 • 2015 ACR/ARHP Annual Meeting

    Comparison of Knee Osteoarthritis Treatment in the Non-Obese Versus Obese Populations Across Different Medical Specialties

    Kelly Forrester1, Farah Taufiq1 and Jonathan Samuels2,3, 1NYU Langone Medical Center, New York, NY, 2Rheumatology, NYU - Hospital for Joint Diseases, New York, NY, 3Rheumatology, NYU Langone Medical Center, New York, NY

    Background/Purpose:   Knee osteoarthritis (KOA) in the obese population is underdiagnosed and routinely undertreated, as providers often attribute pain to excess weight without considering articular…
  • Abstract Number: 897 • 2015 ACR/ARHP Annual Meeting

    Intra-Articular Corticosteroids Are Safe and Have No Major Effect on Structural Progression of Synovitic Knee OA: A 2-Year Randomized Controlled Trial of 3-Monthly Triamcinolone Hexacetonide

    Jeffrey Driban1, Michael P. Lavalley2, Lori Lyn Price3, William F. Harvey4 and Timothy E. McAlindon4, 1Tufts Medical Center, Boston, MA, 2Biostatistics, Boston University, Boston, MA, 3Clinical Care Research, Tufts Medical Center, Boston, MA, 4Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Synovitis is common in knees with OA, and is associated with structural progression. Intra-articular corticosteroids are widely used and could reduce knee OA cartilage…
  • Abstract Number: 2409 • 2015 ACR/ARHP Annual Meeting

    Factors Associated with Physical Therapy Use in Osteoarthritis of the Knee: Results from a Population-Based Study

    Sicong Huang1, Eric C. Sayre2 and Jolanda Cibere1,2, 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis. Physical therapy (PT) has previously been demonstrated to benefit patients with osteoarthritis, especially with early…
  • Abstract Number: 928 • 2015 ACR/ARHP Annual Meeting

    The Value of Early Ultrasound-Detected Osteophytes in Hand Osteoarthritis: Predicting the Future

    Alexander Mathiessen1, Barbara Slatkowsky-Christensen2, Tore K. Kvien3, Ida K. Haugen4 and Hilde Berner Hammer2, 1Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4P.O. Box 23, Diakonhjemmet Hospital, Vinderen, Norway

    Background/Purpose: Ultrasound is more sensitive than conventional radiographs in detecting small osteophytes in hand osteoarthritis (OA). Osteophytes can be seen prior to joint space narrowing…
  • Abstract Number: 2411 • 2015 ACR/ARHP Annual Meeting

    Patient Preference for Using Technology to Track and Self-Manage Osteoarthritis

    Laura Khurana, Ellen Durand, Sarah Gary, Tony Otero, Chris Hall and Susan Dallabrida, ERT, Boston, MA

    Background/Purpose: Active and consistent self-management is essential for patients suffering from chronic diseases to improve their health.  Electronic clinical (eClinical) technology may improve how patients…
  • Abstract Number: 951 • 2015 ACR/ARHP Annual Meeting

    Comparative Effectiveness of Tai Chi Versus Physical Therapy in Treating Knee Osteoarthritis: A Randomized, Single-Blind Trial

    Chenchen Wang1,2, Christopher Schmid3, Maura D. Iversen4, William F. Harvey2, Roger A. Fielding5, Jeffrey B. Driban2, Lori Lyn Price6, John B. Wong7,8, Kieran Reid5, Ramel Rones9 and Timothy E. McAlindon2, 1Rheumatology, Tufts Medical Center, Bosotn, MA, 2Rheumatology, Tufts Medical Center, Boston, MA, 3Brown University School of Public Health, Providence, RI, 4Northeastern University,, Boston, MA, 5Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, 6Clinical Care Research, Tufts Medical Center, Boston, MA, 7Tufts Medical Center, Boston, MA, 8Clinical Decision Making, Tufts Medical Center, Boston, MA, 9Center for Mind–Body Therapies, Boston, MA

    Background/Purpose: Knee osteoarthritis (OA) causes long-term pain and no effective treatments currently exist. Previous trials demonstrated that Tai Chi can improve both physical and mental…
  • Abstract Number: 2412 • 2015 ACR/ARHP Annual Meeting

    Assessment and Comparison of Responsiveness of Four Patient Reported Outcome Measures to Assess Physical Function in Patients with Knee Osteoarthritis: WOMAC-PF Subscale Responds Best

    Elien A.M. Mahler1, Nienke Cuperus2, Johannes W J Bijlsma3, Thea Vliet Vlieland4, Frank H.J. van den Hoogen5, Alfons den Broeder5 and Cornelia H.M. van den Ende1, 1Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Rheumatology Department, Sint Maartenskliniek, Nijmegen, Netherlands, 3Rheumatology and Clinical Immunology, ARC Amsterdam; UMC Utrecht, Utrecht, Netherlands, 4Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

    Background/Purpose: Although physical function is one of the core outcome domains in knee osteoarthritis (OA), the ability of a measurement instrument to detect changes over…
  • Abstract Number: 953 • 2015 ACR/ARHP Annual Meeting

    Effectiveness of a Progressive Resistence Strength Programme on Hand Osteoarthritis: A Randomized Crontrolled Trial

    Michele V. Nery1, Anamaria Martinez2, Fabio Jennings3, Marcelo Souza2 and Jamil Natour2, 1Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 2Rheumatology Division, Federal University of Sao Paulo, Sao Paulo, Brazil, 3Disciplina de reumatologia, Universidade Federal de São Paulo, Sao Paulo, Brazil

    Background/Purpose: Hand osteoarthritis (OA) is highly prevalent, affecting 55-70% of the population over 55 years with an age-related progressive increase. The OA of interphalangeal (IF)…
  • Abstract Number: 2617 • 2015 ACR/ARHP Annual Meeting

    Serum 14-3-3eta Protein Elevation in Osteoarthritis Suggests Misclassification or Concurrent Inflammatory Arthritis

    Olga S. Zhukov1, Jonnielyn G. Rivera1, Rania W. Abolhosn1, Robert J. Lagier2, Charles M. Rowland3, Joanna M. Popov1, Kaleb Michaud4 and Stanley J. Naides1, 1Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, 2Research Support, Alameda, Quest Diagnostics Alameda, Alameda, CA, 3Research Support, Quest Diagnostics Alameda, Alameda, CA, 4Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE

    Background/Purpose: Tissue distribution of the chaperonin 14-3-3η (eta) is limited to synovial tissue and brain. Synovium releases proinflammatory 14-3-3η into synovial fluid and serum in…
  • Abstract Number: 1150 • 2015 ACR/ARHP Annual Meeting

    Novel Chitosan Hydrogels for the Treatment of Osteoarthritis: Mechanical Support, Lubrication and Prevention of Cartilage Degradation in a Rabbit Model of Osteoarthritis

    Yves Henrotin1,2, Frédéric Oprenyeszk1, Fanny Comblain3, Jean-Emile Dubuc4, Christelle Boileau5, Mickaël Chausson6, Renaud Lecler6, Guillem Rocasalbas6, Pierre Douette6 and Sandrine Gautier6, 1Bone and Cartilage Research Unit, Arthropôle Liege, University of Liege, Liege, Belgium, 2Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Marche-en-Famenne, Belgium, 3University of Liège, Bone and Cartilage Research Unit, Arthropôle Liege, University of Liege, Liege, Belgium, 4Clinical University Saint Luc, Orthopaedic Department, Clinical University Saint Luc, Brussels, Belgium, 5Artialis S.A.,11 Avenue de l’Hôpital, Tour Giga+3, Liege, Belgium, 6Synolyne Pharma, rue Haute Claire 4, Herstal, Belgium

    Background/Purpose: Chitosan, a glucosamine polysaccharide, is a good candidate for viscosupplementation in OA joints. Herein, we report the physico-chemical properties and the effects of an…
  • Abstract Number: 3086 • 2015 ACR/ARHP Annual Meeting

    The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia

    Kathryn A. Gibson1, Annie Huang2 and Theodore Pincus2, 1Liverpool Hospital, Liverpool, Australia, 2Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: An MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data) is a 2 sided, 1 page questionnaire which is completed by patients in…
  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 71
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology